Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha

Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2021-05, Vol.184 (5), p.966-967
Hauptverfasser: Marques, E., Arenberger, P., Smetanová, A., Gkalpakiotis, S., Zimová, D., Arenbergerová, M.
Format: Artikel
Sprache:eng
Schlagworte:
Monoclonal antibodies
Necrosis
Tumor necrosis factor
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 967
container_issue 5
container_start_page 966
container_title British journal of dermatology (1951)
container_volume 184
creator Marques, E.
Arenberger, P.
Smetanová, A.
Gkalpakiotis, S.
Zimová, D.
Arenbergerová, M.
description
doi_str_mv 10.1111/bjd.19716
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2483406532</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2521856889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3536-c6f8b0e0592b21394fa936e121ebfbf899ef49728869df7d21216de3387e2b5b3</originalsourceid><addsrcrecordid>eNp1kbtuVDEQhi1ERDaBghdAlmhIcRJf9vjYJQmXgCJRALVl-4y1Xs4NX4hCRcED8Ix5ErzZQIGEm5E133ya0Y_QU0pOaX1ndtufUtVR8QCtKBdtwyjnD9GKENI1RAl-iI5S2hJCOWnJI3TIOSdUELpCPz8W5yAlXwacI5g8wpTx7HEEZwYXcjT1vwl9ND1MIYeEU1mWEk0O3wy-DnmDY0hm-hK-l9FYbHyGiL0JQ4mwE9X5cPvjVy7jXCKewMU5VYs3Ls8Rm2HZmMfowJshwZP7eow-v3n96eKyufrw9t3Fy6vG8ZaLxgkvLQHSKmbrhWrtjeICKKNgvfVSKfBr1TEphep917PaET1wLjtgtrX8GL3Ye5c4fy2Qsh5DcjAMZoK5JM3Wkq-JaDmr6PN_0G1df6rbadYyKlshparUyZ7aHZUieL3EMJp4oynRu2h0jUbfRVPZZ_fGYkfo_5J_sqjA2R64DgPc_N-kz9-_2it_A5jCm24</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2521856889</pqid></control><display><type>article</type><title>Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Wiley Online Library All Journals</source><creator>Marques, E. ; Arenberger, P. ; Smetanová, A. ; Gkalpakiotis, S. ; Zimová, D. ; Arenbergerová, M.</creator><creatorcontrib>Marques, E. ; Arenberger, P. ; Smetanová, A. ; Gkalpakiotis, S. ; Zimová, D. ; Arenbergerová, M.</creatorcontrib><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/bjd.19716</identifier><identifier>PMID: 33301601</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Monoclonal antibodies ; Necrosis ; Tumor necrosis factor ; Tumors</subject><ispartof>British journal of dermatology (1951), 2021-05, Vol.184 (5), p.966-967</ispartof><rights>2020 British Association of Dermatologists</rights><rights>Copyright © 2021 British Association of Dermatologists</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3536-c6f8b0e0592b21394fa936e121ebfbf899ef49728869df7d21216de3387e2b5b3</citedby><cites>FETCH-LOGICAL-c3536-c6f8b0e0592b21394fa936e121ebfbf899ef49728869df7d21216de3387e2b5b3</cites><orcidid>0000-0003-1451-6115</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fbjd.19716$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fbjd.19716$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33301601$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marques, E.</creatorcontrib><creatorcontrib>Arenberger, P.</creatorcontrib><creatorcontrib>Smetanová, A.</creatorcontrib><creatorcontrib>Gkalpakiotis, S.</creatorcontrib><creatorcontrib>Zimová, D.</creatorcontrib><creatorcontrib>Arenbergerová, M.</creatorcontrib><title>Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><subject>Monoclonal antibodies</subject><subject>Necrosis</subject><subject>Tumor necrosis factor</subject><subject>Tumors</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp1kbtuVDEQhi1ERDaBghdAlmhIcRJf9vjYJQmXgCJRALVl-4y1Xs4NX4hCRcED8Ix5ErzZQIGEm5E133ya0Y_QU0pOaX1ndtufUtVR8QCtKBdtwyjnD9GKENI1RAl-iI5S2hJCOWnJI3TIOSdUELpCPz8W5yAlXwacI5g8wpTx7HEEZwYXcjT1vwl9ND1MIYeEU1mWEk0O3wy-DnmDY0hm-hK-l9FYbHyGiL0JQ4mwE9X5cPvjVy7jXCKewMU5VYs3Ls8Rm2HZmMfowJshwZP7eow-v3n96eKyufrw9t3Fy6vG8ZaLxgkvLQHSKmbrhWrtjeICKKNgvfVSKfBr1TEphep917PaET1wLjtgtrX8GL3Ye5c4fy2Qsh5DcjAMZoK5JM3Wkq-JaDmr6PN_0G1df6rbadYyKlshparUyZ7aHZUieL3EMJp4oynRu2h0jUbfRVPZZ_fGYkfo_5J_sqjA2R64DgPc_N-kz9-_2it_A5jCm24</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Marques, E.</creator><creator>Arenberger, P.</creator><creator>Smetanová, A.</creator><creator>Gkalpakiotis, S.</creator><creator>Zimová, D.</creator><creator>Arenbergerová, M.</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1451-6115</orcidid></search><sort><creationdate>202105</creationdate><title>Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha</title><author>Marques, E. ; Arenberger, P. ; Smetanová, A. ; Gkalpakiotis, S. ; Zimová, D. ; Arenbergerová, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3536-c6f8b0e0592b21394fa936e121ebfbf899ef49728869df7d21216de3387e2b5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Monoclonal antibodies</topic><topic>Necrosis</topic><topic>Tumor necrosis factor</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marques, E.</creatorcontrib><creatorcontrib>Arenberger, P.</creatorcontrib><creatorcontrib>Smetanová, A.</creatorcontrib><creatorcontrib>Gkalpakiotis, S.</creatorcontrib><creatorcontrib>Zimová, D.</creatorcontrib><creatorcontrib>Arenbergerová, M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marques, E.</au><au>Arenberger, P.</au><au>Smetanová, A.</au><au>Gkalpakiotis, S.</au><au>Zimová, D.</au><au>Arenbergerová, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2021-05</date><risdate>2021</risdate><volume>184</volume><issue>5</issue><spage>966</spage><epage>967</epage><pages>966-967</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><cop>England</cop><pub>Oxford University Press</pub><pmid>33301601</pmid><doi>10.1111/bjd.19716</doi><tpages>0</tpages><orcidid>https://orcid.org/0000-0003-1451-6115</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0007-0963
ispartof British journal of dermatology (1951), 2021-05, Vol.184 (5), p.966-967
issn 0007-0963
1365-2133
language eng
recordid cdi_proquest_miscellaneous_2483406532
source Oxford University Press Journals All Titles (1996-Current); Wiley Online Library All Journals
subjects Monoclonal antibodies
Necrosis
Tumor necrosis factor
Tumors
title Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti‐tumour necrosis factor alpha
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T14%3A06%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20treatment%20of%20recalcitrant%20hidradenitis%20suppurativa%20with%20risankizumab%20after%20failure%20of%20anti%E2%80%90tumour%20necrosis%20factor%20alpha&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Marques,%20E.&rft.date=2021-05&rft.volume=184&rft.issue=5&rft.spage=966&rft.epage=967&rft.pages=966-967&rft.issn=0007-0963&rft.eissn=1365-2133&rft_id=info:doi/10.1111/bjd.19716&rft_dat=%3Cproquest_cross%3E2521856889%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2521856889&rft_id=info:pmid/33301601&rfr_iscdi=true